Female Lewis rats (150 – 170g; Charles River Laboratories) were house standard shoebox cages, fed Harlan-Tekald diet and water ad libitum and maintained on a 12h light/dark cycle. For induction of arthritis rats were anesthetized with isofluorane and their entire dorsal area shaved. Rats were injected (intradermal) with 100 μl of equal volumes of collagen (Chrondrex, Redmond, WA) and IFA (Sigma Chemicals, St. Louis, MO) emulsion in 10 sites across the dorsal region. At disease onset 11 days following immunization animals were randomized into groups based on their ankle measurements and test article administration was initiated. Rats were dosed orally with vehicle (20%
Captisol®),
Indomethacin (Sigma Chemicals, St. Louis, MO, 2mg/kg) or CC-509 (15, 25mg/kg QD or 15mg/kg BID) in a dose volume of 5ml/kg. Paw swelling was assessed by caliper measurements on day 11, 12, 13, 14, 15 and 18 post-immunization and % inhibition calculated at day 18 compared to the vehicle control or area under the curve (AUC) calculated from day 11–18. On the last day of the study animals were split into 2 cohorts and bleed twice via tail bleed under isofluorane anesthesia and a third terminal bleed following CO
2 asphyxiation to obtain a time course of plasma compound exposure at 30minutes, 1, 2, 4, 8 and 24h after the last dose of CC-509.
Ferguson G.D., Delgado M., Plantevin-Krenitsky V., Jensen-Pergakes K., Bates R.J., Torres S., Celeridad M., Brown H., Burnett K., Nadolny L., Tehrani L., Packard G., Pagarigan B., Haelewyn J., Nguyen T., Xu L., Tang Y., Hickman M., Baculi F., Pierce S., Miyazawa K., Jackson P., Chamberlain P., LeBrun L., Xie W., Bennett B, & Blease K. (2016). A Novel Triazolopyridine-Based Spleen Tyrosine Kinase Inhibitor That Arrests Joint Inflammation. PLoS ONE, 11(1), e0145705.